Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Protagen, BioAnalytix & GeneWerk Rebrand as ProtaGene (2022-01-12)
Following the announced merger in July 2021, Protagen Protein Services GmbH, BioAnalytix, Inc., and GeneWerk GmbH today announced their unified operations and re-brand as ProtaGene, a world-leading CRO partner for the biopharmaceutical and cell & gene therapy indus...
Scitara Raises $15m Series B Led by Northpond Ventures (2022-01-11)
Scitara Corp., a proven innovator in laboratory digital transformation, today announces the closing of its Series B round with an additional investment of $15m. Led by existing investor Northpond Ventures, with participation from Flybridge Capital and experienced f...
Malvern Panalytical Acquires Creoptix AG (2022-01-11)
Creoptix joins Malvern Panalytical family Malvern Panalytical, a company providing advanced analysis and services solutions for the pharma drug product development, as well as services and solutions for other industries, has today announced its acquisition of ...
Bayer & Mammoth Biosciences Partner for in vivo Gene Editing (2022-01-10)
> Agreement strengthens Bayer’s new cell and gene therapy platform further > Supports Mammoth’s vision of unlocking the full potential of novel CRISPR systems > Mammoth to receive upfront payment of USD 40 million, and potential future milestone payments of m...
Exscientia & Sanofi: up to $5.3b Research Collaboration (2022-01-07)
> Collaborative efforts aim to accelerate drug discovery and improve clinical success > Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine platform from target identification through patient selection > Research will be focused ...
Electochaea Closes €36m Series D Financing Round (2022-01-07)
Power-to-gas company Electrochaea announced today a €14.9 million equity investment from the European Innovation Council (EIC) Fund. This investment completes the €36 million Series D round, led by the energy technology company Baker Hughes and existing partners MV...
Novartis & Alnylam to Explore Targeted Liver Therapy (2022-01-06)
> Agreement will bring Alnylam’s proprietary siRNA technology to bear on liver target identified by Novartis researchers > Novartis and Alnylam have agreed to collaborate on discovery and development of siRNA-based targeted therapy to restore functional liver ce...
Merck to Acquire Biopharma CDMO Exelead for $780m in Cash (2022-01-06)
> Targeted acquisition to accelerate novel modalities service offering > Exelead, a full-service CDMO, focusing on Lipid Nanoparticle formulations enhances Merck’s mRNA and lipid manufacturing capabilities > Customers will benefit from unique and integrated s...
PhoreMost & POLARISqb: Multi-target Cancer Collaboration (2022-01-05)
PhoreMost Limited, a UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, and Polaris Quantum Biotech (POLARISqb), a NC-based quantum computing drug design company, today announced a collaboration to study oncology t...
T-knife Therapeutics Appoints Ronald Krasnow General Counsel (2022-01-05)
T-knife Therapeutics, Inc., a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer, today announced the appointment of Ronald Krasnow, J.D., who brings over thirty years of legal counsel and executive management experience to T-knife...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] No Content Marketing 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]